Humoral immunity induced by XEC monovalent vaccines against SARS-CoV-2 variants including XEC, LP.8.1, NB.1.8.1, XFG, and BA.3.2
Keiya Uriu, Yu Kaku, Yusuke Kosugi, Luo Chen, Naoya Itoh, Yoshifumi Uwamino, Hiroshi Fujiwara, Hironori Satoh, Kei Sato
This study evaluates the neutralizing antibody response induced by XEC-based monovalent vaccines against multiple SARS-CoV-2 variants, showing enhanced immunity against JN.1 subvariants compared to other variants.
Vaccine · Feb 10, 2026Peer-reviewedMicrobiology